info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Oxytocin Market Research Report Information By Product (Antepartum and Postpartum), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/20082-HCR | 128 Pages | Author: Rahul Gotadki| July 2024

Global Oxytocin Market Overview


Oxytocin Market Size was valued at USD 0.08 Billion in 2022. The oxytocin market industry is projected to grow from USD 0.088 Billion in 2023 to USD 0.178 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2023 - 2032).  The rising incidence of pregnancy problems, the rise in births worldwide, and the expanding public awareness of induced labor and breastfeeding are the factors propelling the market's expansion.


Oxytocin Market Overview


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Oxytocin Market Trends



  • Increasing number of difficulties during childbirth is driving the market growth


Since oxytocin is frequently used to treat delivery difficulties, the number of cases of these complications has been rising over time and is expected to do so in the years to come. As a result, the market for this medication is expected to rise over the forecast period. According to the Blue Cross Blue Shield Association, women who experience difficulties throughout pregnancy are twice as likely to experience difficulties during childbirth. According to the June 2020 publication "Trends in Pregnancy and Childbirth Complications in the U.S.", between 2014 and 2018, there was a 16.4% increase in pregnancy difficulties and a 14.2% increase in birthing complications. The Blue Cross Blue Shield Association reports that eclampsia was the birthing complication that experienced the greatest growth between 2014 and 2018. In the United States, the prevalence rate of eclampsia grew by 57.9% between 2014 and 2018, rising from 1.1 cases per 1,000 to 1.7 cases per 1,000. The frequency of other problems has also been rising, including cardiomyopathy, embolism, sepsis, and respiratory distress. Oxytocin is becoming more and more necessary to start labor, intensify uterine contractions, and manage postpartum hemorrhage as a result of the rising number of difficulties associated with childbirth. Throughout the projected period, the rising trend of birth abnormalities is anticipated to support the oxytocin market's expansion.


Market expansion is facilitated by cooperative ventures and advancements related to oxytocin. Tonix Pharmaceuticals and Katana Pharmaceuticals, for instance, have a licensing agreement for Tonix's intranasal potentiated oxytocin, per the January 2021 update. In particular, insulin resistance, diabetes, and obesity will see a rise in the use of drugs to treat metabolic disorders. The principal indication for Tonix is migraine, although preclinical results also demonstrate the effectiveness of the intranasal oxytocin product TNX-1900 in disorders of the central nervous system. In June 2020, the company initially purchased oxytocin-potentiated therapy from Trigemina; this arrangement adds to that acquisition. Joint ventures and partnerships connected to oxytocin provide several indications and support the growth of the oxytocin market throughout the projected timeframe. Thus, driving the oxytocin market revenue.


Oxytocin Market Segment Insights


Oxytocin Product Insights


The Oxytocin Market segmentation, based on product includes Antepartum and Postpartum. The postpartum segment dominated the market. Because postpartum oxytocin products have been shown to reduce postpartum hemorrhage, their use and applications are becoming more widely accepted worldwide as a means of reducing mother mortality.


Figure 1: Oxytocin Market, by Product, 2022 & 2032 (USD Billion)


Oxytocin Market, by Product, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Oxytocin Distribution Channel Insights


The Oxytocin Market segmentation, based on distribution channel, includes Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies. The hospital pharmacies category generated the most income. The bulk of oxytocin-related treatments are carried out in hospitals. Hospital networks also support the market for Oxytocin by increasing purchasing power, which makes them a significant Distribution Channel category.


Oxytocin Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American oxytocin market area will dominate this market. Growing national spending on personal care goods and rising awareness of pregnancy products are the main factors driving this market's expansion. An important component of the American healthcare system, maternal and child health has emerged as a result of the increased responsiveness, which has led to the success of initiatives aimed at raising public awareness about pregnancy.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: OXYTOCIN MARKET SHARE BY REGION 2022 (USD Billion)


 OXYTOCIN MARKET SHARE BY REGION 2022


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe oxytocin market accounts for the second-largest market share. Throughout the projection period, Germany is anticipated to be a profitable center for oxytocin product research, development, and manufacture in the European Union due to the presence of major industry players like Novartis that have a significant research impact on the entire market structure. Further, the German oxytocin market held the largest market share, and the UK oxytocin market was the fastest growing market in the European region


The Asia-Pacific Oxytocin Market is expected to grow at the fastest CAGR from 2023 to 2032 owing to a number of variables, including growing disposable income in developing nations like China and India, an expansion of established distribution networks, and increased consumer awareness of oxytocin products as a result of forceful advertising initiatives by significant players. Moreover, China’s oxytocin market held the largest market share, and the Indian oxytocin market was the fastest growing market in the Asia-Pacific region.


Oxytocin Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the oxytocin market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, oxytocin industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global oxytocin industry to benefit clients and increase the market sector. In recent years, the oxytocin industry has offered some of the most significant advantages to medicine. Major players in the oxytocin market are attempting to increase market demand by investing in research and development operations includes Pfizer Inc., Fresenius Kabi LLC, Endo International plc. (Par Sterile Products, LLC), Wockhardt Ltd., Novartis AG, Ferring B.V., Hikma Pharmaceuticals PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation.


Fresenius Kabi USA LLC (also known as Fresenius Kabi), a division of Fresenius Kabi AG, is a pharmaceutical and medical equipment manufacturer offering technologies and medications for clinical nutrition, transfusion, and infusion. It offers goods and services to those who are seriously and persistently unwell. The company provides sophisticated transfusion medicine, infusion, cell therapy, injectable medications, and clinical nutrition technology. Oncology, anesthesia, analgesia, parenteral nutrition, IV solutions, anti-infectives, and other critical care medicines are among its offerings.


Hikma Pharmaceuticals Plc (Hikma) creates, produces, and sells in-licensed goods as well as branded and non-branded generics. Cardiovascular disease, diabetes, cancer, the central nervous system (CNS), dermatology, the genitourinary system, hormones, and the respiratory system are among the specialties of the company. It provides generics in a range of dosage forms, including as tablets, capsules, liquids, and suspensions. Hikma Pharmaceuticals distributes its goods to top wholesalers, pharmacy chains, governments, and hospital buying organizations through sales and marketing teams and representatives.


Key Companies in the oxytocin market include



  • Pfizer Inc.

  • Fresenius Kabi LLC

  • Endo International plc. (Par Sterile Products, LLC)

  • Wockhardt Ltd.

  • Novartis AG

  • Ferring B.V.

  • Hikma Pharmaceuticals PLC

  • Mylan N.V.

  • Teva Pharmaceutical Industries Ltd.

  • Sun Pharmaceutical Industries Ltd.

  • Yuhan Corporation


Oxytocin Industry Developments


August 2022:The US patent for the painkiller intranasal oxytocin (TNX-1900) was awarded to Tonix Pharmaceuticals. Under the heading "Magnesium-Containing Oxytocin Formulations and Methods of Use," the patent sought to protect patients from pain—including migraine headaches—by employing intranasal formulations of oxytocin that contain magnesium. Tonix should have U.S. market exclusivity through January 2036 thanks to this invention, barring any potential patent term extensions.


May 2020:Carbetocin Ferring, a heat-stable formulation approved by Swissmedic, is used to prevent postpartum hemorrhage in all births. This drug is the first to be approved under the new MAGHP (Marketing Authorization for Global Health Products) and Swissmedic procedures.


Oxytocin Market Segmentation


Oxytocin Product Outlook



  • Antepartum

  • Postpartum


Oxytocin Distribution Channel Outlook



  • Hospital Pharmacies

  • Retail Pharmacies

  • Drug Stores

  • Online Pharmacies


Oxytocin Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Attribute/Metric Details
Market Size 2022 USD 0.08 Billion
Market Size 2023 USD 0.088 Billion
Market Size 2032 USD 0.178 Billion
Compound Annual Growth Rate (CAGR) 9.20% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Distribution Channel, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Pfizer Inc., Fresenius Kabi LLC, Endo International plc. (Par Sterile Products, LLC), Wockhardt Ltd., Novartis AG, Ferring B.V., Hikma Pharmaceuticals PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation
Key Market Opportunities ·       Improvements to the Drug Delivery System
Key Market Dynamics ·       Growing Concerns about Maternal Healthcare ·       Growing Number of Mental Health Conditions


Frequently Asked Questions (FAQ) :

The Oxytocin Market size was valued at USD 0.08 Billion in 2022.

The global market is projected to grow at a CAGR of 9.20% during the forecast period, 2023-2032.

North America had the largest share in the global market

The key players in the market are Pfizer Inc., Fresenius Kabi LLC, Endo International plc. (Par Sterile Products, LLC), Wockhardt Ltd., Novartis AG, Ferring B.V., Hikma Pharmaceuticals PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation.

The postpartum category dominated the market in 2022.

The hospital pharmacies category had the largest share in the global market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.